Anne-Marie Wills, MD, MPH, is a physician-scientist specializing in Parkinson's Disease, ALS and related neurodegenerative diseases.
- Movement Disorders Clinic: 617-726-5532
Research Investigator Profile
Anne-Marie Wills, MD, MPH
- Assistant Professor of Neurology,
Harvard Medical School
- Associate in Neurology,
Massachusetts General Hospital
Dr. Wills is interested in environmental risk factors and determinants of neurodegenerative disease progression including nutrition, caffeine and pesticides.
She is currently the Principal Investigator of a multi-center clinical trial funded by the Muscular Dystrophy Association to study the effects of increasing the caloric intake of ALS (Lou Gehrig's Disease) patients. Studies from both human and animal research data have shown an increase in longevity where mild obesity is present.
Dr. Wills is the Mass General Investigator on several Parkinson's Disease clinical trials testing therapeutic interventions in PD, and an investigator with the Parkinson's Study Group, and the Net-PD exploratory trials in Parkinson's Disease.
|Research interests||Environmental risk factors, determinants of neurodegenerative disease progression|
|Research techniques||Human and animal research studies|
|Diseases studied||Amyotrophic Lateral Sclerosis, Parkinson's disease|
|NCBI PubMed link||NCBI PubMed publications|
|Collaborators||Co-authors (on Harvard Catalyst)|
|Lab mailing address||
|Clinical interests||Movement disorders, neurodegenerative disease, motor neuron disease|
|Clinical address||Massachusetts General Hospital
Neurology, Suite 835
Wang Ambulatory Care Center
55 Fruit Street
Boston, MA 02114 USA
|Clinical website address||Amyotrophic Lateral Sclerosis Multidisciplinary Clinic
Movement Disorders Unit